Edition:
United Kingdom

Array Biopharma Inc (ARRY.OQ)

ARRY.OQ on NASDAQ Stock Exchange Global Market

15.86USD
13 Dec 2018
Change (% chg)

$-0.28 (-1.73%)
Prev Close
$16.14
Open
$16.17
Day's High
$16.31
Day's Low
$15.38
Volume
1,113,028
Avg. Vol
728,344
52-wk High
$20.20
52-wk Low
$10.54

Select another date:

Wed, Jun 27 2018

Photo

Array BioPharma gets FDA nod for melanoma combo treatment

The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.

UPDATE 2-Array BioPharma gets FDA nod for melanoma combo treatment

June 27 The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.

CORRECTED-UPDATE 1-FDA approves Array BioPharma's melanoma combo treatment

June 27 The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.

CORRECTED-Array's melanoma combo treatment wins FDA approval

June 27 The U.S. Food and Drug Administration said on Wednesday it had approved Array BioPharma Inc's combination treatment for use in patients with the deadliest form of skin cancer.

Select another date: